
Lambda Therapeutic Research
Full-service global CRO and biologics CDMO
Full-service global CRO offering Phase I–IV clinical trial management, pharmacovigilance, and bioanalytical labs, plus biologics CDMO services. Has supported 280+ clinical trials across 15+ therapeutic domains.
Phases
Indications / Therapeutic Areas
Services
- Bioanalysis
- Clinical Trial Services
- Phase I Clinical Trials
- Phase II Clinical Trials
- Phase III Clinical Trials
- Phase IV / Post-Marketing
- Clinical Operations
- Data Management & eClinical
- Biostatistics & Statistical Programming
- Pharmacovigilance & Drug Safety
- Medical Writing
- Clinical Imaging Core Lab
- Regulatory Affairs
Modalities
Technical specifications & accreditations
Infrastructure
About this organization
Overview
Lambda Therapeutic Research is a full-service global contract research organization (CRO) that also offers biologics contract development and manufacturing (CDMO) services. The company describes its capabilities as spanning early to late-phase clinical development, supported by global operations, scientific expertise, and regulatory alignment.
Clinical development services
- Phase I–IV clinical trial management, including Phase II–IV clinical trial management
- Clinical Development Services (CDS) project management
- Regulatory affairs and medical writing
- Biostatistics and data management
- Medical affairs
- Clinical safety and pharmacovigilance
- Medical imaging
- eTMF and quality assurance
- Strategic product development and consulting
Laboratories and technology
The site lists bioanalytical laboratories and a Phase-I unit among its facilities and technology offerings.
Therapeutic experience
The company reports experience supporting over 280 clinical trials across more than 15 therapeutic domains. Listed areas include oncology and hematology, dermatology, neuroscience, biosimilar development, infectious disease, pulmonology, cardiovascular and metabolic disorders, gastroenterology, nephrology, ophthalmology, and musculoskeletal conditions.
Regulatory record
The company states that a recent unannounced US FDA inspection of its bioanalytical operations concluded with zero Form 483 observations. It also reports that a US FDA pharmacovigilance inspection concluded with zero Form 483 observations.
Similar companies
Similar profiles by shared services, phases, and indications.
Linical- Clinical Trial Services
- Phase I Clinical Trials
ClinActis Pte Ltd- Clinical Trial Services
- Phase I Clinical Trials
Advanced Clinical- Clinical Trial Services
- Phase I Clinical Trials
YPrime- Clinical Trial Services
- Phase I Clinical Trials
OCT Clinical- Phase I Clinical Trials
- Phase II Clinical Trials
Acromion Gmbh- Clinical Trial Services
- Phase I Clinical Trials
BioAgile Therapeutics- Phase I Clinical Trials
- Phase II Clinical Trials
Medidata Solutions- Clinical Trial Services
- Phase I Clinical Trials
View all alternatives →See similar CROs ranked by shared capabilities
Submit a verified review for this organization.
Markdown mirror: /companies/lambda-cro.md